KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Baxter International (BAX) Depreciation and Depletion (2024 - 2025)

Baxter International (BAX) has disclosed Depreciation and Depletion for 2 consecutive years, with $95.0 million as the latest value for Q4 2025.

Quarterly Depreciation and Depletion rose 4.4% to $95.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $383.0 million through Dec 2025, up 2.96% year-over-year, with the annual reading at $383.0 million for FY2025, 2.96% up from the prior year.
Depreciation and Depletion for Q4 2025 was $95.0 million at Baxter International, up from $90.0 million in the prior quarter.
The five-year high for Depreciation and Depletion was $113.0 million in Q1 2024, with the low at $73.0 million in Q2 2024.